Secnidazole

# Secnidazole ## Overview - **Classification**: Nitroimidazole antimicrobial - **Mechanism**: Activated metabolite forms reactive intermediates that bind to and damage bacterial DNA, inhibiting nucleic acid synthesis and leading to cell death. ## Primary Indications 1. **Bacterial Vaginosis (BV)** - Single-dose oral treatment for symptomatic BV. 2. **Trichomoniasis** - Single-dose oral treatment for Trichomonas vaginalis infection. ## Adult Dosing ### Standard Dosing **Bacterial Vaginosis** - **Dose**: **2 g** - **Frequency**: Single dose - **Route**: Oral granules (mixed with soft food) - **Duration**: Single dose **Trichomoniasis** - **Dose**: **2 g** - **Frequency**: Single dose - **Route**: Oral granules (mixed with soft food) - **Duration**: Single dose ### Dose Adjustments - **Renal Impairment**: No dose adjustment needed. - **Hepatic Impairment**: No dose adjustment needed. - **Elderly Patients**: No specific dose adjustment recommended. ## Pediatric Dosing *Note: Secnidazole for Bacterial Vaginosis and Trichomoniasis is not indicated for pediatric patients below 18 years of age due to lack of established safety and efficacy.* *However, secnidazole is used off-label in pediatrics for other protozoal infections like amebiasis or giardiasis in some regions.* ### Neonates (0-28 days) - **Not Recommended**: Safety and efficacy not established. ### Infants (1-12 months) - **Not Recommended**: Safety and efficacy not established for primary indications. ### Children (1-12 years) - **Amebiasis/Giardiasis (Off-label use)** - **Dose**: **30 mg/kg** - **Frequency**: Single dose - **Maximum**: **2 g** - **Special Notes**: Use only for indicated parasitic infections; consult infectious disease specialist. Not for BV/Trichomoniasis. ### Adolescents (13-18 years) - **Bacterial Vaginosis/Trichomoniasis**: Limited data. - **Dose**: If prescribed, may consider adult dose of **2 g** - **Maximum**: **2 g** - **Special Notes**: Only use if clear indication and potential benefits outweigh risks. ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to secnidazole or other nitroimidazole derivatives. - **Absolute**: Pregnancy (particularly 1st trimester). Avoid use in all trimesters unless essential. - **Absolute**: Breastfeeding (discontinue for **96 hours** after dose). ### Common Adverse Effects - **Very Common (>10%)**: Vulvovaginal candidiasis, headache, nausea, dysgeusia (metallic taste). - **Common (1-10%)**: Abdominal pain, diarrhea, vomiting, dizziness, pruritus. - **Serious but Rare**: Leukopenia, neutropenia (transient), peripheral neuropathy. ### Key Drug Interactions - **Alcohol**: Disulfiram-like reaction (flushing, palpitations, nausea, vomiting, abdominal cramps). **AVOID** alcohol during treatment and for **48 hours** after. - **Warfarin**: May potentiate anticoagulant effect. Monitor INR/PT closely. - **Lithium**: May increase lithium levels. Monitor lithium concentrations. - **Disulfiram**: Concomitant use may lead to psychotic reactions. Avoid. ## Monitoring & Follow-up - **Before Treatment**: Pregnancy test (for women of childbearing potential). - **During Treatment**: Assess for resolution of symptoms. - **Clinical Signs**: Monitor for severe GI upset, neurological symptoms (dizziness, paresthesias), or signs of allergic reaction. ## Clinical Pearls - 💡 **Single-dose convenience**: Enhances patient adherence significantly. - 💡 **Granule administration**: Mix entire contents of packet with soft food (e.g., applesauce, yogurt, pudding); do NOT dissolve in liquid. Consume immediately. - 💡 **Alcohol avoidance**: Crucial patient counseling point due to disulfiram-like reaction. - 💡 **Taste masking**: Can have a bitter or metallic taste; mixing with strong-flavored soft foods helps. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.